Evidence map›Paper›PMID 32960313›Full record

Trial reportJournal of orofacial orthopedics = Fortschritte der Kieferorthopadie : Organ/official journal Deutsche Gesellschaft fur Kieferorthopadie2021

Evaluation of effectiveness and stability of aligner treatments using the Peer Assessment Rating Index.

Isabelle Graf, Carolin Puppe, Jörg Schwarze, Karolin Höfer, Hildegard Christ, Bert Braumann

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Journal of orofacial orthopedics = Fortschritte der Kieferorthopadie : Organ/official journal Deutsche Gesellschaft fur Kieferorthopadie, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Orthodontic aligner therapy outcomes in children with autism spectrum disorder.International journal of paediatric dentistry · 2025
    Article
  4. Article
  5. Orthodontic aligners: between passion and science.Dental press journal of orthodontics · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Isabelle GrafDepartment of Orthodontics, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Kerpener Str. 32, 50931, Cologne, Germany. isabelle.graf@uk-koeln.de.
Carolin PuppeDepartment of Orthodontics, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Kerpener Str. 32, 50931, Cologne, Germany.
Jörg SchwarzePrivate Orthodontic Practice, Cologne, Germany.
Karolin HöferDepartment of Operative Dentistry and Periodontology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
Hildegard ChristInstitute of Medical Statistics and Computational Biology, University Hospital of Cologne, Cologne, Germany.
Bert BraumannDepartment of Orthodontics, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Kerpener Str. 32, 50931, Cologne, Germany.
University Hospital Cologne · DEUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe aims of this study were to measure treatment effects of aligner treatments in adult patients directly after treatment and the stability of these effects after a short-term retention period using the Peer Assessment Rating (PAR) Index.

methodsThis double-center trial consecutively screened 98 adult patients of whom 33 patients were treated according to predefined inclusion and exclusion criteria. The study sample was shown to be representative for adult orthodontic reality with regard to gender, age, and distribution of malocclusion type. Malocclusion severity was rated by using the PAR Index measured at baseline (T0), after finishing orthodontic treatment with Invisalign® (T1; Align Technology Inc., Santa Clara, CA, USA) and after a mean retention period of 10 months (T2). Furthermore, to better understand the observed treatment modality, specific treatment characteristics were recorded and analyzed.

resultsThe average PAR score at T0 was 22.18 (standard deviation [SD] ± 8.68). Posttreatment PAR score was 4.64 (SD ± 4.23) at T1 and was stable after a retention period of 10.07 months at T2 (SD ± 126.80 days; PAR 4.36, SD ± 3.93). All of the study cases showed a significant reduction of the total PAR score between T0 and T1 (p < 0.001), but no further difference between T1 and T2 (PAR 4.64 vs. 4.36). Cases were either classified 'improved' (n = 23) or 'greatly improved' (n = 10); no case was classified into the third PAR Index category 'worse or no different'. On average, 72 aligners (SD ± 22) with 12 attachments per treatment (SD ± 4) were used to align teeth. Six patients needed a case refinement with a mean of 23 (SD ± 8) further aligners. The maximum number of needed ClinCheck® (Align Technology Inc., Santa Clara, CA, USA) treatment plan revisions was 18 (mean 7, SD ± 4).

conclusionThe detected improvement rate indicated a good standard of orthodontic treatment using aligners. Treatment effects were stable throughout a short-term retention period using a specific retention protocol. Effectiveness and stability were equally achieved in mild, moderate, and rather severe cases within this consecutive sample. A critical focus should be placed on accurate treatment planning in order to make tooth movements predictable, realistic, and stable.

Indexed as

MalocclusionOrthodontic Appliances, RemovableAdultHumansTooth Movement TechniquesTreatment OutcomeClear aligner appliancesMalocclusionStabilityTreatment outcome

Identifiers

PMID32960313
OpenAlexW3087344652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.